Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea; Department of Neurology, National Health Insurance Service Ilsan Hospital, Goyang, South Korea.
Department of Biomedical Engineering, Hanyang University, Seoul, South Korea.
Neurobiol Aging. 2019 Jun;78:168-177. doi: 10.1016/j.neurobiolaging.2019.02.023. Epub 2019 Mar 11.
This study aimed to investigate whether reversion to cognitively normal status (CogN) is related to a favorable cognitive prognosis in Parkinson's disease with mild cognitive impairment (PD-MCI). We recruited 217 patients with PD-MCI who underwent serial neuropsychological assessments 3-5 times (mean interval, 1.84 years). Thirty-six patients reverted to CogN (reverters) during follow-up, whereas the other 181 did not (nonreverters). We assessed the risk of cognitive worsening in PD-MCI reverters, nonreverters, and patients with PD-CogN (n = 88). In addition, we performed comparative analyses of comprehensive neuroimaging studies between the PD-MCI reverter (n = 17) and nonreverter (n = 34) subgroups. PD-MCI reverters had a lower risk of dementia conversion than nonreverters. In addition, PD-MCI reverters had similar risks of cognitive worsening with patients with PD-CogN. PD-MCI reverters exhibited greater cortical thickness in the right parahippocampal gyrus and less severely decreased functional connectivity in the default mode and executive control networks relative to nonreverters. Our results suggest that PD-MCI reverters have relatively preserved structural and functional integrity and a favorable cognitive prognosis compared with nonreverters.
这项研究旨在探讨认知正常状态(CogN)的恢复是否与帕金森病伴轻度认知障碍(PD-MCI)的有利认知预后相关。我们招募了 217 名 PD-MCI 患者,他们接受了 3-5 次连续的神经心理学评估(平均间隔 1.84 年)。36 名患者在随访期间恢复到 CogN(恢复者),而其他 181 名患者没有(非恢复者)。我们评估了 PD-MCI 恢复者、非恢复者和 PD-CogN 患者(n=88)认知恶化的风险。此外,我们还对 PD-MCI 恢复者(n=17)和非恢复者(n=34)亚组的综合神经影像学研究进行了比较分析。PD-MCI 恢复者发生痴呆转化的风险低于非恢复者。此外,PD-MCI 恢复者与 PD-CogN 患者的认知恶化风险相似。与非恢复者相比,PD-MCI 恢复者右侧海马旁回皮质厚度更大,默认模式和执行控制网络的功能连接下降程度较轻。我们的研究结果表明,与非恢复者相比,PD-MCI 恢复者具有相对较好的结构和功能完整性,认知预后较好。